North Star Asset Management Inc. grew its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 2.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 48,571 shares of the medical research company’s stock after purchasing an additional 1,126 shares during the period. North Star Asset Management Inc.’s holdings in Thermo Fisher Scientific were worth $7,461,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. State of New Jersey Common Pension Fund D raised its holdings in shares of Thermo Fisher Scientific by 11.8% during the third quarter. State of New Jersey Common Pension Fund D now owns 95,000 shares of the medical research company’s stock worth $17,974,000 after purchasing an additional 10,000 shares during the period. Aperio Group LLC raised its holdings in shares of Thermo Fisher Scientific by 9.9% during the third quarter. Aperio Group LLC now owns 345,539 shares of the medical research company’s stock worth $65,376,000 after purchasing an additional 31,185 shares during the period. Trust Co. of Vermont raised its holdings in shares of Thermo Fisher Scientific by 1.2% during the third quarter. Trust Co. of Vermont now owns 37,685 shares of the medical research company’s stock worth $7,130,000 after purchasing an additional 450 shares during the period. Huntington National Bank raised its holdings in shares of Thermo Fisher Scientific by 2.4% during the third quarter. Huntington National Bank now owns 195,348 shares of the medical research company’s stock worth $36,959,000 after purchasing an additional 4,655 shares during the period. Finally, Saratoga Research & Investment Management acquired a new stake in shares of Thermo Fisher Scientific during the third quarter worth $260,000. 83.78% of the stock is currently owned by institutional investors.

A number of analysts have weighed in on TMO shares. Leerink Swann increased their target price on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 target price on the stock in a report on Thursday, September 21st. Cowen and Company reissued an “outperform” rating and set a $220.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Deutsche Bank AG set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Finally, BidaskClub cut shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. One investment analyst has rated the stock with a hold rating and sixteen have given a buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus price target of $205.71.

In related news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the transaction, the chief executive officer now owns 252,577 shares in the company, valued at approximately $47,582,981.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the transaction, the vice president now owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The disclosure for this sale can be found here. Insiders sold a total of 60,420 shares of company stock valued at $11,308,477 in the last quarter. 0.49% of the stock is currently owned by insiders.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at $190.17 on Friday. The stock has a market cap of $76,257.22, a PE ratio of 20.90, a P/E/G ratio of 1.74 and a beta of 1.08. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. Thermo Fisher Scientific’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.03 EPS. equities analysts forecast that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be given a $0.15 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.

TRADEMARK VIOLATION NOTICE: This report was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://theolympiareport.com/2017/11/19/north-star-asset-management-inc-raises-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.